Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Larp1b | Rat | (-)-demecolcine | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of LARP1B mRNA | CTD | PMID:23649840 | Larp1b | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Larp1b (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LARP1B mRNA | CTD | PMID:22206623 | Larp1b | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Larp1b (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of LARP1B mRNA | CTD | PMID:17555576 | Larp1b | Rat | 17beta-estradiol | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | Estradiol affects the expression of LARP1B mRNA | CTD | PMID:22574217 | Larp1b | Rat | 17beta-estradiol | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Estradiol results in increased expression of LARP1B mRNA | CTD | PMID:31614463 | Larp1b | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of LARP1B mRNA | CTD | PMID:32145629 | Larp1b | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of LARP1B mRNA | CTD | PMID:29581250 | Larp1b | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of LARP1B mRNA | CTD | PMID:19095052 | Larp1b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Larp1b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LARP1B mRNA | CTD | PMID:21570461 | Larp1b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LARP1B mRNA | CTD | PMID:20959002|PMID:21215274 | Larp1b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LARP1B mRNA | CTD | PMID:18691609 | Larp1b | Rat | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of LARP1B mRNA | CTD | PMID:30723492 | Larp1b | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | bisphenol S results in increased expression of LARP1B mRNA | CTD | PMID:39298647 | Larp1b | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of LARP1B mRNA | CTD | PMID:31881176 | Larp1b | Rat | all-trans-retinoic acid | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of LARP1B mRNA | CTD | PMID:33167477 | Larp1b | Rat | antirheumatic drug | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of LARP1B mRNA | CTD | PMID:24449571 | Larp1b | Rat | aristolochic acid A | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of LARP1B mRNA | CTD | PMID:33212167 | Larp1b | Rat | arsane | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LARP1B more ... | CTD | PMID:39836092 | Larp1b | Rat | arsenic atom | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LARP1B more ... | CTD | PMID:39836092 | Larp1b | Rat | benzo[a]pyrene | decreases expression | ISO | Larp1b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of LARP1B mRNA | CTD | PMID:22228805 | Larp1b | Rat | benzo[a]pyrene | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of LARP1B mRNA | CTD | PMID:32234424 | Larp1b | Rat | benzo[a]pyrene | decreases methylation | ISO | LARP1B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of LARP1B 5' UTR | CTD | PMID:27901495 | Larp1b | Rat | benzo[a]pyrene | affects methylation | ISO | LARP1B (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LARP1B promoter | CTD | PMID:27901495 | Larp1b | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LARP1B mRNA | CTD | PMID:26238291 | Larp1b | Rat | beta-lapachone | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of LARP1B mRNA | CTD | PMID:38218311 | Larp1b | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Larp1b (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of LARP1B mRNA | CTD | PMID:33754040 | Larp1b | Rat | bisphenol A | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | bisphenol A affects the expression of LARP1B mRNA | CTD | PMID:30903817 | Larp1b | Rat | bisphenol A | affects methylation | ISO | LARP1B (Homo sapiens) | 6480464 | bisphenol A affects the methylation of LARP1B gene | CTD | PMID:31601247 | Larp1b | Rat | bisphenol A | decreases expression | ISO | Larp1b (Mus musculus) | 6480464 | bisphenol A results in decreased expression of LARP1B mRNA | CTD | PMID:33221593 | Larp1b | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LARP1B mRNA | CTD | PMID:32145629 | Larp1b | Rat | bisphenol F | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | bisphenol F results in increased expression of LARP1B mRNA | CTD | PMID:38685157 | Larp1b | Rat | Bufotalin | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | bufotalin results in decreased expression of LARP1B mRNA | CTD | PMID:39904859 | Larp1b | Rat | butanal | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of LARP1B mRNA | CTD | PMID:26079696 | Larp1b | Rat | Butylbenzyl phthalate | decreases expression | ISO | Larp1b (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased expression of LARP1B mRNA | CTD | PMID:28392331 | Larp1b | Rat | caffeine | increases phosphorylation | ISO | LARP1B (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of LARP1B protein | CTD | PMID:35688186 | Larp1b | Rat | calcitriol | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of LARP1B mRNA | CTD | PMID:16002434 | Larp1b | Rat | carbamazepine | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | Carbamazepine affects the expression of LARP1B mRNA | CTD | PMID:25979313 | Larp1b | Rat | carbon nanotube | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of LARP1B mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Larp1b | Rat | cisplatin | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of LARP1B mRNA | CTD | PMID:27392435 | Larp1b | Rat | clorgyline | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Clorgyline results in increased expression of LARP1B mRNA | CTD | PMID:19691856 | Larp1b | Rat | copper(II) sulfate | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of LARP1B mRNA | CTD | PMID:19549813 | Larp1b | Rat | crocidolite asbestos | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in increased expression of LARP1B mRNA | CTD | PMID:18687144 | Larp1b | Rat | crocidolite asbestos | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | Asbestos, Crocidolite results in increased expression of LARP1B mRNA | CTD | PMID:29279043 | Larp1b | Rat | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of LARP1B mRNA | CTD | PMID:21865292 | Larp1b | Rat | cyclosporin A | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LARP1B mRNA | CTD | PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131 | Larp1b | Rat | dexamethasone | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of LARP1B mRNA | CTD | PMID:25047013 | Larp1b | Rat | Dibutyl phosphate | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of LARP1B mRNA | CTD | PMID:37042841 | Larp1b | Rat | dicrotophos | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of LARP1B mRNA | CTD | PMID:28302478 | Larp1b | Rat | dioxygen | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of LARP1B mRNA | CTD | PMID:22629407 | Larp1b | Rat | dioxygen | multiple interactions | ISO | Larp1b (Mus musculus) | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of LARP1B mRNA] | CTD | PMID:22629407 | Larp1b | Rat | dorsomorphin | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Larp1b | Rat | enzyme inhibitor | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Larp1b | Rat | epoxiconazole | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | epoxiconazole results in increased expression of LARP1B mRNA | CTD | PMID:35436446 | Larp1b | Rat | ethanol | affects expression | ISO | Larp1b (Mus musculus) | 6480464 | Ethanol affects the expression of LARP1B mRNA | CTD | PMID:30319688 | Larp1b | Rat | ethyl methanesulfonate | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of LARP1B mRNA | CTD | PMID:23649840 | Larp1b | Rat | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of LARP1B mRNA | CTD | PMID:24136188 | Larp1b | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of LARP1B mRNA | CTD | PMID:23962444 | Larp1b | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of LARP1B mRNA | CTD | PMID:24136188 | Larp1b | Rat | folic acid | multiple interactions | ISO | Larp1b (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LARP1B mRNA | CTD | PMID:22206623 | Larp1b | Rat | formaldehyde | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of LARP1B mRNA | CTD | PMID:23649840 | Larp1b | Rat | FR900359 | increases phosphorylation | ISO | LARP1B (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of LARP1B protein | CTD | PMID:37730182 | Larp1b | Rat | geldanamycin | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | geldanamycin results in increased expression of LARP1B mRNA | CTD | PMID:26705709 | Larp1b | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of LARP1B mRNA | CTD | PMID:33387578 | Larp1b | Rat | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of LARP1B mRNA | CTD | PMID:24136188 | Larp1b | Rat | gold atom | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Gold results in decreased expression of LARP1B mRNA | CTD | PMID:25523186 | Larp1b | Rat | gold(0) | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Gold results in decreased expression of LARP1B mRNA | CTD | PMID:25523186 | Larp1b | Rat | ivermectin | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of LARP1B protein | CTD | PMID:32959892 | Larp1b | Rat | lead diacetate | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | lead acetate results in increased expression of LARP1B mRNA | CTD | PMID:21829687 | Larp1b | Rat | lead diacetate | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LARP1B mRNA | CTD | PMID:22839698 | Larp1b | Rat | menadione | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of LARP1B mRNA | CTD | PMID:20044591 | Larp1b | Rat | methyl methanesulfonate | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of LARP1B mRNA | CTD | PMID:23649840 | Larp1b | Rat | nickel atom | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Nickel results in increased expression of LARP1B mRNA | CTD | PMID:25583101 | Larp1b | Rat | okadaic acid | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of LARP1B mRNA | CTD | PMID:38832940 | Larp1b | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of LARP1B mRNA | CTD | PMID:25729387 | Larp1b | Rat | ozone | multiple interactions | ISO | Larp1b (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... | CTD | PMID:34911549 | Larp1b | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of LARP1B mRNA | CTD | PMID:33387578 | Larp1b | Rat | phenylmercury acetate | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Larp1b | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of LARP1B mRNA | CTD | PMID:28374803 | Larp1b | Rat | SB 431542 | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Larp1b | Rat | sodium arsenite | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LARP1B mRNA; sodium arsenite results in decreased expression more ... | CTD | PMID:28595984|PMID:30528433|PMID:34032870 | Larp1b | Rat | sodium arsenite | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LARP1B more ... | CTD | PMID:39836092 | Larp1b | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of LARP1B mRNA | CTD | PMID:19281266 | Larp1b | Rat | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of LARP1B mRNA | CTD | PMID:24136188 | Larp1b | Rat | thimerosal | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Thimerosal results in increased expression of LARP1B mRNA | CTD | PMID:27188386 | Larp1b | Rat | thiram | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Thiram results in increased expression of LARP1B mRNA | CTD | PMID:38568856 | Larp1b | Rat | titanium dioxide | increases methylation | ISO | Larp1b (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of LARP1B promoter | CTD | PMID:35295148 | Larp1b | Rat | titanium dioxide | decreases methylation | ISO | Larp1b (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of LARP1B gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Larp1b | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of LARP1B mRNA | CTD | PMID:25729387 | Larp1b | Rat | trichostatin A | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | trichostatin A results in increased expression of LARP1B mRNA | CTD | PMID:24935251 | Larp1b | Rat | trichostatin A | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | trichostatin A affects the expression of LARP1B mRNA | CTD | PMID:28542535 | Larp1b | Rat | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of LARP1B mRNA | CTD | PMID:30589522 | Larp1b | Rat | triptonide | increases expression | ISO | Larp1b (Mus musculus) | 6480464 | triptonide results in increased expression of LARP1B mRNA | CTD | PMID:33045310 | Larp1b | Rat | tunicamycin | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of LARP1B mRNA | CTD | PMID:22378314 | Larp1b | Rat | urethane | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Urethane results in increased expression of LARP1B mRNA | CTD | PMID:28818685 | Larp1b | Rat | valproic acid | affects expression | ISO | LARP1B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LARP1B mRNA | CTD | PMID:23179753|PMID:25979313 | Larp1b | Rat | valproic acid | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of LARP1B mRNA | CTD | PMID:27188386 | Larp1b | Rat | valproic acid | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Larp1b | Rat | valproic acid | increases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LARP1B mRNA | CTD | PMID:26272509|PMID:28001369|PMID:29154799 | Larp1b | Rat | valproic acid | increases methylation | ISO | LARP1B (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of LARP1B gene | CTD | PMID:29154799 | Larp1b | Rat | vincristine | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | Vincristine results in decreased expression of LARP1B mRNA | CTD | PMID:23649840 | Larp1b | Rat | vorinostat | decreases expression | ISO | LARP1B (Homo sapiens) | 6480464 | vorinostat results in decreased expression of LARP1B mRNA | CTD | PMID:27188386 | Larp1b | Rat | zinc atom | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of LARP1B mRNA | CTD | PMID:18593933 | Larp1b | Rat | zinc protoporphyrin | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LARP1B mRNA | CTD | PMID:22839698 | Larp1b | Rat | zinc(0) | multiple interactions | ISO | LARP1B (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of LARP1B mRNA | CTD | PMID:18593933 | |






















